DFTX compared with BTMD: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

BTMDbiote Corp.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

BTMDbiote Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

Q1 FY26±12.9%▲+0.93%×0.07

Jan 12 '26—▲+0.29%—

BTMD

Reportimpliedrealized× implied

Nov 5 '26—▼−15.45%—

Q2 FY26—▼−27.88%—

May 7 '26

= impliedDFTX realized, solidBTMD realized, hatchedOne scale, both sides: full bar = 28%× = |realized| ÷ impliedSource: market data

—

▼−5.00%

—

Q1 FY26—▼−10.47%—

DFTXDefinium Therapeutics, Inc.

33.27▲+9.57%· post 33.05

Mkt cap$4.5BRevenue—Revenue—

BTMDbiote Corp.

1.04▲+0.19%· post 1.05

ClosedNov 6 '26

Mkt cap$38.1MRevenue$44MQ2 FY26Revenue$192MFY25

Compare

ClosedNov 6 '26

DFTXDefinium Therapeutics, Inc.

BTMDbiote Corp.

33.27▲+9.57%post 33.05

Price

1.04▲+0.19%post 1.05

$4.5B

Mkt cap

$38.1M

—

Revenue

$44MQ2 FY26

—

Revenue

$192MFY25

DFTX33.27▲+9.57%vsBTMD1.04▲+0.19%ClosedNov 6 '26